Document is current
Any future updates will be listed below
-
Authors
Krackhardt, Florian https://orcid.org/0000-0001-5965-8817
Bonaventura, Klaus https://orcid.org/0000-0001-9581-4637
Waliszewski, Matthias https://orcid.org/0000-0002-8689-4505
Rosenberg, Mark
Verdoia, Monica https://orcid.org/0000-0001-6506-8397
Zeymer, Uwe
Koning, Rene https://orcid.org/0000-0003-4107-5124
Landolff, Quentin https://orcid.org/0000-0003-4022-2065
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 25 September 2025
Accepted: 23 November 2025
First Online: 8 January 2026
Declarations
:
: FK received lecture fees from Novartis, Böhringer, Cordis, Bristol Myers Squibb, Daiichi Sankyo and is a consultant with Lilly and B. Braun. KB received lecture fees from B. Braun. MWW is a full-time employee of B. Braun Vascular Systems, Berlin. UZ received lecture fees from AstraZeneca, BMS, Boehringer Ingelheim, Bayer Healthcare, Chiesi, Daiichi Sankyo, Ferrer, Fresenius, Getinge, Meril, Medtronic, Novartis, Pfizer, Sanofi, Zoll. MR, MV, UW, RB and QL do not have a conflict of interest.
